Connect Biopharma HldgsCNTB

13F holders, Q3 2025 (September 30)
1holders −16
0new positions
6sold out
$1.51avg. 13F price*

At the end of Q3 2025, 1 institutions reported holding Connect Biopharma Hldgs Ltd. (CNTB) in their 13F filings, down 16 from Q2 2025. 0 opened new positions and 6 sold out. The largest holder was EverSource Wealth Advisors, LLC ($2K).

Company
Connect Biopharma Hldgs Ltd.
CUSIP
207523101
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 12Q1 2024Q2 2024: 12Q2 2024Q3 2024: 11Q3 2024Q4 2024: 14Q4 2024Q1 2025: 13Q1 2025Q2 2025: 17Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits6$368K

All 13F filers, Q2 2025 → Q3 2025: 373,559 shares sold, net −373,559 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

EverSource Wealth Advisors, LLC 0.00% No change 1,582 $2K

"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Hldgs Ltd. the manager owns.